HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $417,000 | -58.7% | 6,591 | -65.4% | 0.00% | -33.3% |
Q4 2021 | $1,010,000 | +221.7% | 19,048 | +304.7% | 0.00% | +200.0% |
Q2 2021 | $314,000 | -86.6% | 4,707 | -77.7% | 0.00% | -92.9% |
Q1 2021 | $2,339,000 | +107.4% | 21,072 | +121.9% | 0.01% | +75.0% |
Q4 2020 | $1,128,000 | -53.7% | 9,498 | -65.9% | 0.01% | -75.8% |
Q3 2020 | $2,434,000 | -72.1% | 27,893 | -71.4% | 0.03% | -76.6% |
Q2 2020 | $8,723,000 | +110.3% | 97,393 | +134.0% | 0.14% | +33.0% |
Q1 2020 | $4,148,000 | +103.7% | 41,625 | +134.9% | 0.11% | +783.3% |
Q4 2019 | $2,036,000 | -18.3% | 17,721 | -14.4% | 0.01% | -50.0% |
Q2 2019 | $2,492,000 | +1127.6% | 20,705 | +920.5% | 0.02% | +1100.0% |
Q4 2018 | $203,000 | -95.5% | 2,029 | -96.0% | 0.00% | -96.7% |
Q2 2018 | $4,515,000 | +2102.4% | 50,342 | +1327.7% | 0.06% | +1400.0% |
Q4 2017 | $205,000 | -69.0% | 3,526 | -76.1% | 0.00% | -69.2% |
Q3 2017 | $662,000 | – | 14,754 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |